.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Cantor Fitzgerald
Farmers Insurance
Novartis
Colorcon
Citi
UBS
Fish and Richardson
McKesson

Generated: July 27, 2017

DrugPatentWatch Database Preview

Sodium benzoate; sodium phenylacetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium benzoate; sodium phenylacetate and what is the scope of sodium benzoate; sodium phenylacetate patent protection?

Sodium benzoate; sodium phenylacetate
is the generic ingredient in three branded drugs marketed by Maia Pharms Inc, B Braun, Medicis, Navinta Llc, and Ailex Pharms Pvt Ltd, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand three hundred and ninety-two drug master file entries for sodium benzoate; sodium phenylacetate. Seven suppliers are listed for this compound.

Summary for Generic Name: sodium benzoate; sodium phenylacetate

Tradenames:3
Patents:0
Applicants:5
NDAs:5
Drug Master File Entries: see list1392
Suppliers / Packagers: see list7
Clinical Trials: see list2,378
Drug Prices:see low prices
DailyMed Link:sodium benzoate; sodium phenylacetate at DailyMed

Pharmacology for Ingredient: sodium benzoate; sodium phenylacetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Navinta Llc
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)205880-001Aug 4, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Ailex Pharms Pvt Ltd
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)207096-001Feb 24, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
B Braun
UCEPHAN
sodium benzoate; sodium phenylacetate
SOLUTION;ORAL019530-001Dec 23, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Medicis
AMMONUL
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)020645-001Feb 17, 2005APRXYesYes► Subscribe► Subscribe► Subscribe
Maia Pharms Inc
SODIUM PHENYLACETATE AND SODIUM BENZOATE
sodium benzoate; sodium phenylacetate
SOLUTION;IV (INFUSION)208521-001May 8, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sodium benzoate; sodium phenylacetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
B Braun
UCEPHAN
sodium benzoate; sodium phenylacetate
SOLUTION;ORAL019530-001Dec 23, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Merck
Boehringer Ingelheim
AstraZeneca
Deloitte
Harvard Business School
Fuji
Chinese Patent Office
Express Scripts
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot